Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
21.69 USD +3.19% Intraday chart for Walgreens Boots Alliance, Inc. +4.28% -16.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dow, S&P 500 Close at Record Highs as Traders Parse Macro Data MT
Dow, S&P 500 Close at Record Highs as Traders Parse Macro Data MT
US Equity Markets Mixed Thursday Following Upwardly Revised Q4 Economic Growth MT
Sector Update: Health Care Stocks Rise Late Afternoon MT
Walgreens Boots Alliance's Fiscal Q2 Non-GAAP Earnings, Sales Rise; Fiscal 2024 Adjusted EPS Outlook Revised MT
News Highlights : Top Company News of the Day - Thursday at 3 PM ET DJ
Equities poised to wrap up strong quarter on quiet note RE
Economic Data Leave Equity Markets Mixed Intraday MT
Top Midday Stories: Bankman-Fried Gets 25-Year Prison Sentence; Home Depot Acquiring SRS Distribution; Walgreens Lowers FY 2024 Outlook; Analyst Says Short MicroStrategy; Canadian School Boards Sue Social Media Platforms; Eli Lilly Weight-Loss Drug Facing Shortage MT
Sector Update: Health Care Stocks Advance in Afternoon Trading MT
Sector Update: Health Care MT
News Highlights : Top Company News of the Day - Thursday at 1 PM ET DJ
News Highlights : Top Company News of the Day - Thursday at 11 AM ET DJ
Walgreens Lowers Top End of Fiscal 2024 Earnings Outlook Following Second-Quarter Beat MT
Investors only care for Easter Our Logo
News Highlights : Top Company News of the Day - Thursday at 9 AM ET DJ
Walgreens Boots: reduction in annual targets CF
Transcript : Walgreens Boots Alliance, Inc., Q2 2024 Earnings Call, Mar 28, 2024
Wall St set to open flat ahead of Easter break, eyes sharp Q1 gains RE
Futures Edge Down Pre-Bell as Traders Await Key Economic Reports; Asia Mixed, Europe Higher MT
Walgreens Boots Alliance's Fiscal Q2 Non-GAAP Earnings, Sales Rise; Fiscal 2024 Adjusted EPS Outlook Revised MT
Holiday Caution Caps Wall Street; Asia Mixed, Europe Up MT
Earnings Flash (WBA) WALGREENS BOOTS ALLIANCE Posts Q2 EPS $1.20, vs. Street Est of $0.82 MT
Walgreens narrows full-year profit forecast and takes $5.8 billion impairment RE
Walgreens Boots Alliance, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
Chart Walgreens Boots Alliance, Inc.
More charts
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
21.02 USD
Average target price
25.29 USD
Spread / Average Target
+20.31%
Consensus
  1. Stock
  2. Equities
  3. Stock Walgreens Boots Alliance, Inc. - Nasdaq
  4. News Walgreens Boots Alliance, Inc.
  5. Walgreens to Buy Remaining Shares in GEHE-Alliance Healthcare JV from McKesson for Undisclosed Sum